These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34782326)

  • 1. Germline Cancer Susceptibility Gene Testing in Unselected Patients with Hepatobiliary Cancers: A Multi-Center Prospective Study.
    Uson Junior PL; Kunze KL; Golafshar MA; Riegert-Johnson D; Boardman L; Borad MJ; Ahn D; Sonbol MB; Faigel DO; Fukami N; Pannala R; Barrus K; Mountjoy L; Esplin ED; Nussbaum RL; Stewart AK; Bekaii-Saab T; Samadder NJ
    Cancer Prev Res (Phila); 2022 Feb; 15(2):121-128. PubMed ID: 34782326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline Cancer Testing in Unselected Patients with Gastric and Esophageal Cancers: A Multi-center Prospective Study.
    Uson PLS; Kunze KL; Golafshar MA; Botrus G; Riegert-Johnson D; Boardman L; Borad MJ; Ahn D; Sonbol MB; Kahn A; Klint M; Esplin ED; Nussbaum RL; Stewart AK; Bekaii-Saab T; Samadder NJ
    Dig Dis Sci; 2022 Nov; 67(11):5107-5115. PubMed ID: 35122589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome.
    Samadder NJ; Riegert-Johnson D; Boardman L; Rhodes D; Wick M; Okuno S; Kunze KL; Golafshar M; Uson PLS; Mountjoy L; Ertz-Archambault N; Patel N; Rodriguez EA; Lizaola-Mayo B; Lehrer M; Thorpe CS; Yu NY; Esplin ED; Nussbaum RL; Sharp RR; Azevedo C; Klint M; Hager M; Macklin-Mantia S; Bryce AH; Bekaii-Saab TS; Sekulic A; Stewart AK
    JAMA Oncol; 2021 Feb; 7(2):230-237. PubMed ID: 33126242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline Cancer Susceptibility Gene Testing in Unselected Patients With Colorectal Adenocarcinoma: A Multicenter Prospective Study.
    Uson PLS; Riegert-Johnson D; Boardman L; Kisiel J; Mountjoy L; Patel N; Lizaola-Mayo B; Borad MJ; Ahn D; Sonbol MB; Jones J; Leighton JA; Gurudu S; Singh H; Klint M; Kunze KL; Golafshar MA; Esplin ED; Nussbaum RL; Stewart AK; Bekaii-Saab TS; Jewel Samadder N
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):e508-e528. PubMed ID: 33857637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.
    Mandelker D; Zhang L; Kemel Y; Stadler ZK; Joseph V; Zehir A; Pradhan N; Arnold A; Walsh MF; Li Y; Balakrishnan AR; Syed A; Prasad M; Nafa K; Carlo MI; Cadoo KA; Sheehan M; Fleischut MH; Salo-Mullen E; Trottier M; Lipkin SM; Lincoln A; Mukherjee S; Ravichandran V; Cambria R; Galle J; Abida W; Arcila ME; Benayed R; Shah R; Yu K; Bajorin DF; Coleman JA; Leach SD; Lowery MA; Garcia-Aguilar J; Kantoff PW; Sawyers CL; Dickler MN; Saltz L; Motzer RJ; O'Reilly EM; Scher HI; Baselga J; Klimstra DS; Solit DB; Hyman DM; Berger MF; Ladanyi M; Robson ME; Offit K
    JAMA; 2017 Sep; 318(9):825-835. PubMed ID: 28873162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline Genetic Testing in Unselected Squamous and Non-Squamous Head and Neck Cancers.
    Brake DA; Idler BM; Kunze KL; Golafshar MA; Heald B; Young S; Klint M; Barrus K; Esplin ED; Nussbaum RL; Samadder NJ; Hinni ML; Chang BA
    Laryngoscope; 2023 Dec; 133(12):3378-3388. PubMed ID: 37132629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Impact of Pathogenic Germline Variants in Pancreatic Cancer: Results From a Multicenter, Prospective, Universal Genetic Testing Study.
    Uson PLS; Samadder NJ; Riegert-Johnson D; Boardman L; Borad MJ; Ahn D; Sonbol MB; Faigel DO; Fukami N; Pannala R; Kunze K; Golafshar M; Klint M; Esplin ED; Nussbaum RL; Stewart AK; Bekaii-Saab T
    Clin Transl Gastroenterol; 2021 Oct; 12(10):e00414. PubMed ID: 34620795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline Genetic Associations for Hepatobiliary Cancers.
    Chotiprasidhi P; Sato-Espinoza AK; Wangensteen KJ
    Cell Mol Gastroenterol Hepatol; 2024; 17(4):623-638. PubMed ID: 38163482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multigene Panel Testing in Individuals With Hepatocellular Carcinoma Identifies Pathogenic Germline Variants.
    Mezina A; Philips N; Bogus Z; Erez N; Xiao R; Fan R; Olthoff KM; Reddy KR; Samadder NJ; Nielsen SM; Hatchell KE; Esplin ED; Rustgi AK; Katona BW; Hoteit MA; Nathanson KL; Wangensteen KJ
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34250406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Germline Findings Among Tumors From Cancer Types Lacking Hereditary Testing Guidelines.
    Yap TA; Ashok A; Stoll J; Mauer E; Nepomuceno VM; Blackwell KL; Garber JE; Meric-Bernstam F
    JAMA Netw Open; 2022 May; 5(5):e2213070. PubMed ID: 35594047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers.
    Jahn A; Rump A; Widmann TJ; Heining C; Horak P; Hutter B; Paramasivam N; Uhrig S; Gieldon L; Drukewitz S; Kübler A; Bermudez M; Hackmann K; Porrmann J; Wagner J; Arlt M; Franke M; Fischer J; Kowalzyk Z; William D; Weth V; Oster S; Fröhlich M; Hüllein J; Valle González C; Kreutzfeldt S; Mock A; Heilig CE; Lipka DB; Möhrmann L; Hanf D; Oleś M; Teleanu V; Allgäuer M; Ruhnke L; Kutz O; Knurr A; Laßmann A; Endris V; Neumann O; Penzel R; Beck K; Richter D; Winter U; Wolf S; Pfütze K; Geörg C; Meißburger B; Buchhalter I; Augustin M; Aulitzky WE; Hohenberger P; Kroiss M; Schirmacher P; Schlenk RF; Keilholz U; Klauschen F; Folprecht G; Bauer S; Siveke JT; Brandts CH; Kindler T; Boerries M; Illert AL; von Bubnoff N; Jost PJ; Metzeler KH; Bitzer M; Schulze-Osthoff K; von Kalle C; Brors B; Stenzinger A; Weichert W; Hübschmann D; Fröhling S; Glimm H; Schröck E; Klink B
    Ann Oncol; 2022 Nov; 33(11):1186-1199. PubMed ID: 35988656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline alterations in patients with biliary tract cancers: A spectrum of significant and previously underappreciated findings.
    Maynard H; Stadler ZK; Berger MF; Solit DB; Ly M; Lowery MA; Mandelker D; Zhang L; Jordan E; El Dika I; Kemel Y; Ladanyi M; Robson ME; O'Reilly EM; Abou-Alfa GK
    Cancer; 2020 Jan; 126(9):1995-2002. PubMed ID: 32012241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic applications of germline testing for cancer predisposition genes in Asia in the real world.
    Cheo SW; Ong PY; Ow SGW; Chan GHJ; Tan DSP; Lim YW; Kong HL; Wong ALA; Lim SE; Walsh RJ; Wong ASC; Low JJH; Ngoi NYL; Lim JSL; Lee SC
    ESMO Open; 2024 Jun; 9(6):103482. PubMed ID: 38833967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening.
    Cremin C; Lee MK; Hong Q; Hoeschen C; Mackenzie A; Dixon K; McCullum M; Nuk J; Kalloger S; Karasinska J; Scudamore C; Kim PTW; Donnellan F; Lam ECS; Lim HJ; Neben CL; Stedden W; Zhou AY; Schaeffer DF; Sun S; Renouf DJ; Schrader KA
    Cancer Med; 2020 Jun; 9(11):4004-4013. PubMed ID: 32255556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline pathogenic variants in unselected Korean men with prostate cancer.
    So MK; Ahn HK; Huh J; Kim KH
    Investig Clin Urol; 2022 May; 63(3):294-300. PubMed ID: 35534218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinoma.
    Brand R; Borazanci E; Speare V; Dudley B; Karloski E; Peters MLB; Stobie L; Bahary N; Zeh H; Zureikat A; Hogg M; Lee K; Tsung A; Rhee J; Ohr J; Sun W; Lee J; Moser AJ; DeLeonardis K; Krejdovsky J; Dalton E; LaDuca H; Dolinsky J; Colvin A; Lim C; Black MH; Tung N
    Cancer; 2018 Sep; 124(17):3520-3527. PubMed ID: 30067863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of actionable germline pathogenic variants identified through tumor next-generation sequencing in a gynecologic cancer cohort.
    Karpel H; Manderski E; Pothuri B
    Int J Gynecol Cancer; 2023 Jul; 33(7):1044-1050. PubMed ID: 36889816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines.
    Nicolosi P; Ledet E; Yang S; Michalski S; Freschi B; O'Leary E; Esplin ED; Nussbaum RL; Sartor O
    JAMA Oncol; 2019 Apr; 5(4):523-528. PubMed ID: 30730552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Universal Germline Testing of Unselected Cancer Patients Detects Pathogenic Variants Missed by Standard Guidelines without Increasing Healthcare Costs.
    Perkins AT; Haslem D; Goldsberry J; Shortt K; Sittig L; Raghunath S; Giauque C; Snow S; Fulde G; Moulton B; Jones D; Nadauld L
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
    Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
    Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.